Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses
ClinicalTrials.gov study NCT02467270. IPD Sharing: YES. Countries: 21. Publications: 2.
A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01667133. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03215030. IPD Sharing: YES. Countries: 16. Publications: 2.
A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT03708211. IPD Sharing: YES. Countries: 1. Publications: 1.
Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)
ClinicalTrials.gov study NCT04434937. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease
ClinicalTrials.gov study NCT03706456. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03088540. IPD Sharing: YES. Countries: 24. Publications: 4.
Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
ClinicalTrials.gov study NCT04223635. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT02819635. IPD Sharing: YES. Countries: 46. Publications: 13.
A Study of Isatuximab-based Therapy in Participants With Lymphoma
ClinicalTrials.gov study NCT03769181. IPD Sharing: YES. Countries: 7. Publications: 1.
Zanubrutinib, in Combination With Lenalidomide, With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04436107. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03734016. IPD Sharing: YES. Countries: 15. Publications: 10.
Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03410108. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia
ClinicalTrials.gov study NCT03207009. IPD Sharing: YES. Countries: 6. Publications: 1.
Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
ClinicalTrials.gov study NCT01505062. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)
ClinicalTrials.gov study NCT03093480. IPD Sharing: YES. Countries: 10. Publications: 1.
Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
ClinicalTrials.gov study NCT05237284. IPD Sharing: YES. Countries: 13. Publications: 1.
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
ClinicalTrials.gov study NCT02255656. IPD Sharing: YES. Countries: 19. Publications: 9.
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or L
ClinicalTrials.gov study NCT03268954. IPD Sharing: YES. Countries: 20. Publications: 1.
A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02917941. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.